Number of the records: 1  

Pathophysiology of perinatal hypoxic-ischemic encephalopathy – biomarkers, animal models and treatment perspectives

  1. 1.
    SYSNO ASEP0470156
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitlePathophysiology of perinatal hypoxic-ischemic encephalopathy – biomarkers, animal models and treatment perspectives
    Author(s) Riljak, V. (CZ)
    Kraf, J. (CZ)
    Daryanani, A. (CZ)
    Jiruška, Přemysl (FGU-C) RID, ORCID, SAI
    Otáhal, Jakub (FGU-C) RID, ORCID, SAI
    Source TitlePhysiological Research. - : Fyziologický ústav AV ČR, v. v. i. - ISSN 0862-8408
    Roč. 65, Suppl.5 (2016), S533-S545
    Number of pages13 s.
    Languageeng - English
    CountryCZ - Czech Republic
    Keywordshypoxic-ischemic encephalopathy ; excitotoxicity ; oxidative stress ; inflammation ; biomarkers
    Subject RIVFH - Neurology
    R&D ProjectsNV15-33115A GA MZd - Ministry of Health (MZ)
    GA15-08565S GA ČR - Czech Science Foundation (CSF)
    GA14-02634S GA ČR - Czech Science Foundation (CSF)
    LM2015062 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportFGU-C - RVO:67985823
    UT WOS000392030300002
    EID SCOPUS85010005248
    AnnotationHypoxic-ischemic encephalopathy (HIE) is one of the leading pediatric neurological conditions causing long-term disabilities and socio-economical burdens. Nearly 20-50 % of asphyxiated newborns with HIE die within the newborn period and another third will develop severe health consequences and permanent handicaps. HIE is the result of severe systemic oxygen deprivation and reduced cerebral blood flow, commonly occurring in full-term infants. Hypoxic-ischemic changes trigger several molecular and cellular processes leading to cell death and inflammation. Generated reactive oxygen species attack surrounding cellular components resulting in functional deficits and mitochondrial dysfunction. The aim of the present paper is to review present knowledge about the pathophysiology of perinatal hypoxic-ischemic encephalopathy, especially with respect to novel treatment strategies and biomarkers that might enhance early detection of this disorder and thus improve the general outcome of patients.
    WorkplaceInstitute of Physiology
    ContactLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Year of Publishing2017
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.